Gary Slaughter, MD
Dermatology · Charlotte, NCNPI 1770522328
Payments from drug & device makers
Across 1,067 payments — averaging $51.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medimetriks Pharmaceuticals, Inc.$14K
- EPI Health, LLC$7K
- Pfizer$7K
- Incyte Corporation$6K
- Dermavant Sciences, Inc.$4K
- Sanofi$4K
- plus $14K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medimetriks Pharmaceuticals, Inc. | 248 | $13,515 |
| EPI Health, LLC | 58 | $6,788 |
| Pfizer | 110 | $6,571 |
| Incyte Corporation | 12 | $5,771 |
| Dermavant Sciences, Inc. | 85 | $4,432 |
| Sanofi | 59 | $3,594 |
| E.r. Squibb & Sons, L.L.C. | 91 | $2,487 |
| Sun Pharmaceutical Industries Inc. | 91 | $2,024 |
| AbbVie | 33 | $1,339 |
| Novartis | 40 | $1,016 |
| Amgen | 48 | $921 |
| LEO Pharma Inc. | 28 | $719 |
| Johnson & Johnson | 15 | $708 |
| Galderma Laboratories, L.p. | 31 | $699 |
| Regeneron Healthcare Solutions, Inc. | 13 | $672 |
| Janssen Scientific Affairs, LLC | 9 | $657 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 27 | $559 |
| UCB, Inc. | 7 | $536 |
| Organon | 7 | $296 |
| Sanofi-aventis U.S. LLC | 7 | $264 |
| Journey Medical Corporation | 9 | $256 |
| Arcutis Biotherapeutics, Inc. | 5 | $252 |
| Lilly USA, LLC | 4 | $142 |
| Almirall LLC | 6 | $140 |
| Dermira, Inc. | 1 | $123 |
| Mayne Pharma Commercial LLC | 8 | $97 |
| Bristol Myers Squibb | 4 | $89 |
| Sebela Pharmaceuticals Inc. | 3 | $50 |
| Sandoz | 2 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| AstraZeneca | 1 | $22 |
| Fresenius Kabi USA, LLC | 1 | $20 |
| Botanix SB Inc | 1 | $17 |
| Organogenesis Inc. | 1 | $15 |
| Strata Skin Sciences, Inc. | 1 | $8 |
How this compares
$54,851 in reported general payments places this provider in the 90th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Charlotte
- Patrick McElgunnCharlotte$1.6M
- Deborah NixonCharlotte$906K
- Marc DarstCharlotte$829K
- Catherine PointonCharlotte$731K
- Rosalyn GeorgeWilmington$6.5M
- Steven FeldmanWinston Salem$4.3M
- Adnan NasirRaleigh$4.1M
- Christopher SayedChapel Hill$3.3M
- Zoe DraelosHigh Point$3M
- Aida Lugo-SomolinosChapel Hill$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.